Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.21% is 94% above its 5-year average of 0.63%, near the high end of its 5-year range (0.13%–1.30%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.80% above its 12-month average of 1.19%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.21%.
DEBT TO ASSETS RATIO
1.21%
DEBT TO ASSETS RATIO AVG TTM
1.19%
DEBT TO ASSETS RATIO AVG 3Y
0.73%
DEBT TO ASSETS RATIO AVG 5Y
0.63%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+1.80%
CURRENT VS 3Y AVG
+67.11%
CURRENT VS 5Y AVG
+93.62%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
+1004.21%
vs the sector median at left
Arvinas, Inc.
Market Cap
$481.33M
Debt to Assets Ratio
1.21%
TTM Avg
1.19%
3Y Avg
0.73%
5Y Avg
0.63%
Market Cap
$478.54M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$487.30M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$453.70M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$450.64M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arvinas, Inc. (ARVN) | $481.33M | 1.21% | 1.19% | 0.73% | 0.63% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | 0.03% | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.30M | 0.00% | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $471.57M | 0.37% | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | 0.33% | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $491.93M | 0.66% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $468.31M | 0.66% | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | 0.00% | N/A | N/A | N/A |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | 0.01% | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | 0.25% | N/A | N/A | N/A |
Debt/Assets
1.2%
Debt/Equity
0.01
Current Ratio
7.91
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.21% |
| 2026-03-31 | 1.30% |
| 2025-12-31 | 1.24% |
| 2025-09-30 | 1.13% |
| 2025-06-30 | 1.09% |
| 2025-03-31 | 1.05% |
| 2024-12-31 | 0.89% |
| 2024-09-30 | 0.13% |
| 2024-06-30 | 0.16% |
| 2024-03-31 | 0.21% |
| 2023-12-31 | 0.25% |
| 2023-09-30 | 0.38% |
| 2023-06-30 | 0.42% |
| 2023-03-31 | 0.43% |
| 2022-12-31 | 0.43% |
| 2022-09-30 | 0.44% |
| 2022-06-30 | 0.45% |
| 2022-03-31 | 0.46% |
| 2021-12-31 | 0.32% |
| 2021-09-30 | 0.33% |
| 2021-06-30 | 0.87% |
| 2021-03-31 | 1.01% |
| 2020-12-31 | 0.57% |
| 2020-09-30 | 1.58% |
| 2020-06-30 | 1.72% |
| 2020-03-31 | 1.68% |
| 2019-12-31 | 1.45% |
| 2019-09-30 | 2.09% |
| 2019-06-30 | 2.68% |
| 2019-03-31 | 2.56% |
| 2018-12-31 | 1.08% |
| 2018-09-30 | 2.22% |
| 2018-06-30 | 0.22% |
| 2018-03-31 | 0.23% |
| 2017-12-31 | 0.46% |
